| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.06e-05 | 14 | 63 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 5.07e-05 | 23 | 63 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.03e-04 | 29 | 63 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.03e-04 | 29 | 63 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.07e-04 | 149 | 63 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.67e-04 | 34 | 63 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 2.04e-04 | 7 | 63 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | protein kinase binding | LIPE PTPN14 CEACAM5 CEACAM6 ELAVL1 EIF3A ULK1 WNK1 TP73 CEACAM1 | 3.77e-04 | 873 | 63 | 10 | GO:0019901 |
| GeneOntologyMolecularFunction | glycolipid binding | 4.97e-04 | 49 | 63 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | kinase binding | LIPE PTPN14 CEACAM5 CEACAM6 ELAVL1 EIF3A ULK1 WNK1 TP73 CEACAM1 | 8.50e-04 | 969 | 63 | 10 | GO:0019900 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.41e-03 | 70 | 63 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.59e-03 | 73 | 63 | 3 | GO:0170055 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 6.00e-06 | 39 | 63 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 9.65e-06 | 14 | 63 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.20e-05 | 15 | 63 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.20e-05 | 15 | 63 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.20e-05 | 15 | 63 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.20e-05 | 15 | 63 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.48e-05 | 16 | 63 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.79e-05 | 17 | 63 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.79e-05 | 17 | 63 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.79e-05 | 17 | 63 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.14e-05 | 18 | 63 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.98e-05 | 20 | 63 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 3.39e-05 | 60 | 63 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.47e-05 | 21 | 63 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.47e-05 | 21 | 63 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.47e-05 | 21 | 63 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.01e-05 | 22 | 63 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 4.60e-05 | 23 | 63 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.60e-05 | 23 | 63 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.25e-05 | 24 | 63 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 5.25e-05 | 24 | 63 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 5.25e-05 | 24 | 63 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.95e-05 | 25 | 63 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.95e-05 | 25 | 63 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of anoikis | 6.72e-05 | 26 | 63 | 3 | GO:2000209 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 7.34e-05 | 73 | 63 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 7.54e-05 | 27 | 63 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 8.42e-05 | 28 | 63 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 8.60e-05 | 76 | 63 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.38e-05 | 29 | 63 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | digestive tract development | 1.01e-04 | 152 | 63 | 5 | GO:0048565 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.05e-04 | 80 | 63 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.15e-04 | 31 | 63 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.26e-04 | 32 | 63 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.26e-04 | 32 | 63 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.26e-04 | 32 | 63 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 1.33e-04 | 85 | 63 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.39e-04 | 33 | 63 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.39e-04 | 33 | 63 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 1.43e-04 | 375 | 63 | 7 | GO:0001933 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.52e-04 | 34 | 63 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.52e-04 | 34 | 63 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | digestive system development | 1.58e-04 | 167 | 63 | 5 | GO:0055123 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 1.59e-04 | 512 | 63 | 8 | GO:0031400 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.66e-04 | 35 | 63 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.73e-04 | 91 | 63 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.88e-04 | 93 | 63 | 4 | GO:1901184 | |
| GeneOntologyBiologicalProcess | anoikis | 1.96e-04 | 37 | 63 | 3 | GO:0043276 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 2.12e-04 | 178 | 63 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.12e-04 | 38 | 63 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | 2.16e-04 | 401 | 63 | 7 | GO:0042326 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 2.48e-04 | 40 | 63 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.66e-04 | 41 | 63 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | tube development | STARD13 ARHGAP22 CEACAM5 PXDN KLF5 GLI2 CEACAM6 MYOCD RXFP1 WNK1 ALX4 TP73 CEACAM1 | 2.67e-04 | 1402 | 63 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.86e-04 | 42 | 63 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 3.00e-04 | 105 | 63 | 4 | GO:0042267 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 3.46e-04 | 109 | 63 | 4 | GO:0002228 | |
| GeneOntologyBiologicalProcess | circulatory system development | STARD13 ARHGAP22 SGCZ PTPN14 CEACAM5 PXDN KLF5 GLI2 CEACAM6 MYOCD WNK1 TP73 CEACAM1 | 3.51e-04 | 1442 | 63 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.52e-04 | 45 | 63 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 3.75e-04 | 46 | 63 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 3.75e-04 | 46 | 63 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | liver development | 3.80e-04 | 202 | 63 | 5 | GO:0001889 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 3.89e-04 | 442 | 63 | 7 | GO:0050878 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.00e-04 | 47 | 63 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 4.00e-04 | 47 | 63 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 4.00e-04 | 47 | 63 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.07e-04 | 205 | 63 | 5 | GO:0061008 | |
| GeneOntologyBiologicalProcess | lymphocyte migration into lymphoid organs | 4.07e-04 | 10 | 63 | 2 | GO:0097021 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 4.53e-04 | 49 | 63 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 4.53e-04 | 49 | 63 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 4.67e-04 | 118 | 63 | 4 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 4.80e-04 | 50 | 63 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 5.22e-04 | 611 | 63 | 8 | GO:0045859 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 5.27e-04 | 217 | 63 | 5 | GO:0030856 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 5.39e-04 | 52 | 63 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | STARD13 ARHGAP22 CEACAM5 PXDN KLF5 GLI2 CEACAM6 MYOCD WNK1 TP73 CEACAM1 | 5.46e-04 | 1125 | 63 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 5.64e-04 | 124 | 63 | 4 | GO:0001910 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 5.71e-04 | 53 | 63 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 5.72e-04 | 221 | 63 | 5 | GO:0006469 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | 6.20e-04 | 478 | 63 | 7 | GO:0045936 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | 6.36e-04 | 480 | 63 | 7 | GO:0010563 | |
| GeneOntologyBiologicalProcess | vasculature development | STARD13 ARHGAP22 PTPN14 CEACAM5 PXDN KLF5 CEACAM6 MYOCD WNK1 CEACAM1 | 6.63e-04 | 969 | 63 | 10 | GO:0001944 |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.71e-04 | 56 | 63 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 6.89e-04 | 350 | 63 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 7.13e-04 | 232 | 63 | 5 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 7.54e-04 | 134 | 63 | 4 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 7.70e-04 | 236 | 63 | 5 | GO:0033673 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 7.81e-04 | 59 | 63 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | STARD13 ARHGAP22 CEACAM5 PXDN KLF5 CEACAM6 MYOCD WNK1 CEACAM1 | 7.98e-04 | 817 | 63 | 9 | GO:0048514 |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 8.21e-04 | 60 | 63 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 8.61e-04 | 61 | 63 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 8.61e-04 | 61 | 63 | 3 | GO:1902895 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 9.27e-04 | 246 | 63 | 5 | GO:0046890 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 9.46e-04 | 63 | 63 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | secretion by tissue | 9.91e-04 | 64 | 63 | 3 | GO:0032941 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 1.01e-03 | 145 | 63 | 4 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.06e-03 | 147 | 63 | 4 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | STARD13 CEACAM5 IPO7 ABCA5 GLI2 ADCK1 CEACAM6 MYOCD ULK1 TP73 CEACAM1 | 1.07e-03 | 1220 | 63 | 11 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.08e-03 | 66 | 63 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.11e-03 | 686 | 63 | 8 | GO:0043549 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.42e-05 | 16 | 63 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | basal part of cell | 1.39e-04 | 378 | 63 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.58e-04 | 90 | 63 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | U2AF complex | 1.86e-04 | 7 | 63 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | mitochondrial nucleoid | 4.90e-04 | 51 | 63 | 3 | GO:0042645 | |
| GeneOntologyCellularComponent | nucleoid | 4.90e-04 | 51 | 63 | 3 | GO:0009295 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.29e-03 | 157 | 63 | 4 | GO:1902554 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.10e-05 | 35 | 56 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.24e-05 | 36 | 56 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 1.71e-05 | 39 | 56 | 4 | MP:0030022 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 3.62e-05 | 47 | 56 | 4 | MP:0031617 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.98e-05 | 17 | 56 | 3 | MP:0031047 | |
| MousePheno | abnormal cellular glucose uptake | 5.33e-05 | 102 | 56 | 5 | MP:0003925 | |
| MousePheno | decreased cellular glucose uptake | 5.84e-05 | 53 | 56 | 4 | MP:0003926 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.70e-05 | 21 | 56 | 3 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.16e-04 | 24 | 56 | 3 | MP:0014172 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.47e-04 | 67 | 56 | 4 | MP:0004130 | |
| MousePheno | increased abdominal fat pad weight | 1.66e-04 | 27 | 56 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.86e-04 | 28 | 56 | 3 | MP:0020950 | |
| MousePheno | abnormal vascular wound healing | 2.05e-04 | 73 | 56 | 4 | MP:0004883 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.46e-04 | 141 | 56 | 5 | MP:0004499 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.53e-04 | 31 | 56 | 3 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.53e-04 | 31 | 56 | 3 | MP:0008964 | |
| MousePheno | abnormal gland physiology | CEACAM5 CADM1 TRHR ABCA5 CEACAM6 RXFP1 MARK2 ELAC2 TP73 CEACAM1 | 3.69e-04 | 691 | 56 | 10 | MP:0002164 |
| MousePheno | absent sperm fibrous sheath | 4.35e-04 | 8 | 56 | 2 | MP:0030591 | |
| MousePheno | periorbital edema | 4.35e-04 | 8 | 56 | 2 | MP:0001788 | |
| MousePheno | abnormal endocrine gland physiology | 5.83e-04 | 363 | 56 | 7 | MP:0013561 | |
| MousePheno | increased incidence of induced tumors | 6.28e-04 | 173 | 56 | 5 | MP:0002021 | |
| MousePheno | abnormal periorbital region morphology | 6.95e-04 | 10 | 56 | 2 | MP:0030038 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 7.18e-04 | 44 | 56 | 3 | MP:0031023 | |
| Domain | Cse1 | 3.35e-05 | 3 | 63 | 2 | IPR013713 | |
| Domain | Cse1 | 3.35e-05 | 3 | 63 | 2 | PF08506 | |
| Domain | ELAD_HUD_SF | 6.69e-05 | 4 | 63 | 2 | IPR006548 | |
| Domain | U2AF_small | 1.11e-04 | 5 | 63 | 2 | IPR009145 | |
| Domain | V-set | 3.89e-04 | 184 | 63 | 5 | PF07686 | |
| Domain | Ig_I-set | 4.50e-04 | 190 | 63 | 5 | IPR013098 | |
| Domain | I-set | 4.50e-04 | 190 | 63 | 5 | PF07679 | |
| Domain | Hud_Sxl_RNA | 4.95e-04 | 10 | 63 | 2 | IPR002343 | |
| Domain | Ig_V-set | 5.56e-04 | 199 | 63 | 5 | IPR013106 | |
| Domain | IMPORTIN_B_NT | 9.93e-04 | 14 | 63 | 2 | PS50166 | |
| Domain | IBN_N | 1.14e-03 | 15 | 63 | 2 | PF03810 | |
| Domain | IGc2 | 1.17e-03 | 235 | 63 | 5 | SM00408 | |
| Domain | Ig_sub2 | 1.17e-03 | 235 | 63 | 5 | IPR003598 | |
| Domain | IBN_N | 1.30e-03 | 16 | 63 | 2 | SM00913 | |
| Domain | Importin-beta_N | 1.47e-03 | 17 | 63 | 2 | IPR001494 | |
| Domain | Ig_2 | 1.92e-03 | 73 | 63 | 3 | PF13895 | |
| Domain | ARM-like | 2.16e-03 | 270 | 63 | 5 | IPR011989 | |
| Domain | - | 2.26e-03 | 21 | 63 | 2 | 1.10.720.30 | |
| Domain | SAP | 2.48e-03 | 22 | 63 | 2 | PF02037 | |
| Domain | SAP | 2.71e-03 | 23 | 63 | 2 | SM00513 | |
| Domain | IG | 2.91e-03 | 421 | 63 | 6 | SM00409 | |
| Domain | Ig_sub | 2.91e-03 | 421 | 63 | 6 | IPR003599 | |
| Domain | SAP | 3.20e-03 | 25 | 63 | 2 | PS50800 | |
| Domain | SAP_dom | 3.20e-03 | 25 | 63 | 2 | IPR003034 | |
| Domain | ig | 3.87e-03 | 190 | 63 | 4 | PF00047 | |
| Domain | Immunoglobulin | 3.87e-03 | 190 | 63 | 4 | IPR013151 | |
| Domain | RRM_1 | 5.33e-03 | 208 | 63 | 4 | PF00076 | |
| Domain | ARM-type_fold | 5.69e-03 | 339 | 63 | 5 | IPR016024 | |
| Domain | IG_LIKE | 6.14e-03 | 491 | 63 | 6 | PS50835 | |
| Domain | - | 6.69e-03 | 222 | 63 | 4 | 1.25.10.10 | |
| Domain | - | 6.80e-03 | 663 | 63 | 7 | 2.60.40.10 | |
| Domain | Ig-like_dom | 6.88e-03 | 503 | 63 | 6 | IPR007110 | |
| Domain | RRM_dom | 7.23e-03 | 227 | 63 | 4 | IPR000504 | |
| Domain | VWC | 7.28e-03 | 38 | 63 | 2 | SM00214 | |
| Domain | RRM | 7.57e-03 | 230 | 63 | 4 | PS50102 | |
| Domain | C2-set_2 | 8.44e-03 | 41 | 63 | 2 | PF08205 | |
| Domain | CD80_C2-set | 8.44e-03 | 41 | 63 | 2 | IPR013162 | |
| Domain | VWF_dom | 8.84e-03 | 42 | 63 | 2 | IPR001007 | |
| Domain | SAM_2 | 9.25e-03 | 43 | 63 | 2 | PF07647 | |
| Domain | Ig-like_fold | 9.45e-03 | 706 | 63 | 7 | IPR013783 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 25409014 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 31171910 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 9.65e-09 | 14 | 63 | 4 | 26196244 | |
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 26483485 | ||
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 10436421 | ||
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 2.26e-08 | 4 | 63 | 3 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 2.26e-08 | 4 | 63 | 3 | 27748756 | |
| Pubmed | 2.15e-07 | 638 | 63 | 10 | 33239621 | ||
| Pubmed | SLC30A7 U2AF1 LRPPRC PXDN IPO7 CCAR1 ELAVL1 EIF3A ULK1 CLPX WNK1 CNOT1 ELAC2 | 4.69e-07 | 1297 | 63 | 13 | 33545068 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 LRPPRC PTPN14 TCF20 IPO7 CCAR1 ELAVL1 MSH2 EIF3A CLPX KIF18B PUM1 ELAC2 | 7.54e-07 | 1353 | 63 | 13 | 29467282 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CNNM3 LRPPRC PXDN IPO7 INTS7 TTI2 DNAH2 SREBF2 MSH2 PUM1 MINDY1 | 9.24e-07 | 942 | 63 | 11 | 31073040 |
| Pubmed | RESF1 TCF20 TLE5 KLF5 GLI2 NFYC CCAR1 ELAVL2 ELAVL1 EIF3A CLPX PUM1 CNOT1 | 1.39e-06 | 1429 | 63 | 13 | 35140242 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.60e-06 | 13 | 63 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.60e-06 | 13 | 63 | 3 | 1985902 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 10964771 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.60e-06 | 13 | 63 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.60e-06 | 13 | 63 | 3 | 16638824 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 20044046 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 32150576 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 22469976 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.60e-06 | 13 | 63 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.60e-06 | 13 | 63 | 3 | 28035001 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.60e-06 | 13 | 63 | 3 | 12832451 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.60e-06 | 13 | 63 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.60e-06 | 13 | 63 | 3 | 21670291 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.60e-06 | 13 | 63 | 3 | 23935487 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 2702644 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 8380065 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 1279194 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 15331748 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.60e-06 | 13 | 63 | 3 | 22406619 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 7628460 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 25724769 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.60e-06 | 13 | 63 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.60e-06 | 13 | 63 | 3 | 22092845 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 11801635 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 28913658 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 19008452 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.60e-06 | 13 | 63 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.60e-06 | 13 | 63 | 3 | 8500759 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.60e-06 | 13 | 63 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.60e-06 | 13 | 63 | 3 | 23800882 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 15207636 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 19285068 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 21760897 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.60e-06 | 13 | 63 | 3 | 1326665 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 21081647 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.60e-06 | 13 | 63 | 3 | 39168268 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 11483763 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 8402684 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 2164599 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 16619040 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.60e-06 | 13 | 63 | 3 | 8209741 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.60e-06 | 13 | 63 | 3 | 21949477 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 29396368 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 26219866 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 18003729 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 26284027 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 2133556 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.60e-06 | 13 | 63 | 3 | 33352461 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 19406938 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 38381498 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 20739537 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.60e-06 | 13 | 63 | 3 | 29967450 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.60e-06 | 13 | 63 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.60e-06 | 13 | 63 | 3 | 27695943 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 20404914 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 16680193 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 26911181 | ||
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.60e-06 | 13 | 63 | 3 | 32027621 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.60e-06 | 13 | 63 | 3 | 27777319 | |
| Pubmed | 1.60e-06 | 13 | 63 | 3 | 18848945 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.68e-06 | 315 | 63 | 7 | 26777405 | |
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 37531413 | ||
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 23780386 | ||
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 28567513 | ||
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.03e-06 | 14 | 63 | 3 | 34666041 | |
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 19700760 | ||
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 2.03e-06 | 14 | 63 | 3 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 2.03e-06 | 14 | 63 | 3 | 29746166 | |
| Interaction | SMG7 interactions | 5.81e-06 | 319 | 62 | 8 | int:SMG7 | |
| Interaction | CDX2 interactions | 6.72e-06 | 86 | 62 | 5 | int:CDX2 | |
| Interaction | ZNF330 interactions | 8.43e-06 | 446 | 62 | 9 | int:ZNF330 | |
| Interaction | CEACAM5 interactions | 9.85e-06 | 14 | 62 | 3 | int:CEACAM5 | |
| Interaction | U2AF1L4 interactions | 2.59e-05 | 19 | 62 | 3 | int:U2AF1L4 | |
| Interaction | CEACAM1 interactions | 3.54e-05 | 21 | 62 | 3 | int:CEACAM1 | |
| Interaction | STIP1 interactions | U2AF1 LRPPRC PTPN14 IPO8 IPO7 ADCK1 CCAR1 ELAVL1 MSH2 EIF3A PUM1 CNOT1 | 4.79e-05 | 1006 | 62 | 12 | int:STIP1 |
| Interaction | SMAD3 interactions | 6.52e-05 | 447 | 62 | 8 | int:SMAD3 | |
| Interaction | ATXN1 interactions | U2AF1 LRPPRC IPO8 IPO7 KLF5 SREBF2 CCAR1 ELAVL1 EIF3A PUM1 WNK1 CNOT1 | 6.55e-05 | 1039 | 62 | 12 | int:ATXN1 |
| Interaction | POU5F1 interactions | 6.99e-05 | 584 | 62 | 9 | int:POU5F1 | |
| Cytoband | 13q22.1 | 1.21e-04 | 12 | 63 | 2 | 13q22.1 | |
| Cytoband | 12p11.21 | 4.21e-04 | 22 | 63 | 2 | 12p11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.22e-03 | 1192 | 63 | 7 | chr19q13 | |
| Cytoband | 19q13.2 | 1.52e-03 | 164 | 63 | 3 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 2.81e-05 | 24 | 45 | 3 | 906 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.11e-05 | 163 | 45 | 5 | 590 | |
| GeneFamily | Armadillo repeat containing|Importins | 9.04e-04 | 18 | 45 | 2 | 596 | |
| GeneFamily | Immunoglobulin like domain containing | 1.33e-03 | 193 | 45 | 4 | 594 | |
| GeneFamily | RNA binding motif containing | 1.91e-03 | 213 | 45 | 4 | 725 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.86e-03 | 394 | 45 | 5 | 471 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 6.88e-03 | 50 | 45 | 2 | 721 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.88e-03 | 50 | 45 | 2 | 1293 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 7.15e-03 | 51 | 45 | 2 | 870 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 5.45e-06 | 48 | 63 | 4 | MM531 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.41e-07 | 184 | 63 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 160 | 63 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 160 | 63 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.79e-06 | 174 | 63 | 5 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 6.12e-06 | 183 | 63 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.33e-06 | 195 | 63 | 5 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.54e-06 | 196 | 63 | 5 | 79bc7ab96b52b2a542348a13ddd0a4f095698c5e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.54e-06 | 196 | 63 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.97e-06 | 198 | 63 | 5 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.97e-06 | 198 | 63 | 5 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 199 | 63 | 5 | 156354b799346d441dde42dbba09d7bde89ad460 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | proximal-3-Epithelial-Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.41e-06 | 200 | 63 | 5 | 8083047c213488e40b975013e3c5c43f7c0c15b2 | |
| ToppCell | proximal-Epithelial-Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.41e-06 | 200 | 63 | 5 | c6a491d3e2dae6618f25dc3c9aac08f657348168 | |
| ToppCell | proximal-Epithelial-Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.41e-06 | 200 | 63 | 5 | f5d48f521abbd1e07de05f2b3768ad2f9675f1e1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 150 | 63 | 4 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 150 | 63 | 4 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 6.55e-05 | 153 | 63 | 4 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.41e-05 | 168 | 63 | 4 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.63e-05 | 169 | 63 | 4 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.85e-05 | 170 | 63 | 4 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.85e-05 | 170 | 63 | 4 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 173 | 63 | 4 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 176 | 63 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-04 | 176 | 63 | 4 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 177 | 63 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 178 | 63 | 4 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 178 | 63 | 4 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 178 | 63 | 4 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-04 | 178 | 63 | 4 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 179 | 63 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 179 | 63 | 4 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-04 | 179 | 63 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.20e-04 | 179 | 63 | 4 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 180 | 63 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 180 | 63 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 181 | 63 | 4 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 181 | 63 | 4 | bab282cb0d9fc049f6fb094cf8b1fba104f4ea17 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.25e-04 | 181 | 63 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 181 | 63 | 4 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 182 | 63 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 183 | 63 | 4 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.34e-04 | 184 | 63 | 4 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 184 | 63 | 4 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 184 | 63 | 4 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 184 | 63 | 4 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.36e-04 | 185 | 63 | 4 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 186 | 63 | 4 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 186 | 63 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 186 | 63 | 4 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 186 | 63 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 186 | 63 | 4 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-04 | 186 | 63 | 4 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.39e-04 | 186 | 63 | 4 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 186 | 63 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 187 | 63 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.42e-04 | 187 | 63 | 4 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 188 | 63 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 188 | 63 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 188 | 63 | 4 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 189 | 63 | 4 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 63 | 4 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 63 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-04 | 189 | 63 | 4 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 189 | 63 | 4 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 63 | 4 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 63 | 4 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.48e-04 | 189 | 63 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 63 | 4 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland|Airway / Age, Tissue, Lineage and Cell class | 1.48e-04 | 189 | 63 | 4 | c1ea2dc44cf5340378e56e0ffc2e6f64e6c95a58 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.48e-04 | 189 | 63 | 4 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 190 | 63 | 4 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 190 | 63 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.51e-04 | 190 | 63 | 4 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 190 | 63 | 4 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-04 | 191 | 63 | 4 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 191 | 63 | 4 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-04 | 192 | 63 | 4 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-04 | 192 | 63 | 4 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 1.57e-04 | 192 | 63 | 4 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.57e-04 | 192 | 63 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 192 | 63 | 4 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-04 | 192 | 63 | 4 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 193 | 63 | 4 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 193 | 63 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 193 | 63 | 4 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 193 | 63 | 4 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 193 | 63 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 193 | 63 | 4 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 193 | 63 | 4 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | 18-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 1.60e-04 | 193 | 63 | 4 | 5067b0db24f96e26cf3f9437736415f694e7a614 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 194 | 63 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 194 | 63 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 194 | 63 | 4 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-04 | 194 | 63 | 4 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| Drug | AC1L1Z1X | 4.36e-06 | 12 | 63 | 3 | CID000012192 | |
| Drug | 1-methyl-3(p-bromophenyl)-1-nitrosourea | 7.54e-06 | 2 | 63 | 2 | CID000146740 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 9.57e-05 | 42 | 62 | 3 | DOID:8991 (is_marker_for) | |
| Disease | response to tamoxifen | 1.55e-04 | 9 | 62 | 2 | EFO_0009391 | |
| Disease | Global developmental delay | 1.80e-04 | 133 | 62 | 4 | C0557874 | |
| Disease | Alzheimer disease, polygenic risk score | 2.25e-04 | 586 | 62 | 7 | EFO_0030082, MONDO_0004975 | |
| Disease | response to opioid | 2.91e-04 | 61 | 62 | 3 | EFO_0008541 | |
| Disease | magnesium measurement | 3.68e-04 | 66 | 62 | 3 | EFO_0004845 | |
| Disease | lung cancer (is_implicated_in) | 5.15e-04 | 74 | 62 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Phenyllactate (PLA) measurement | 7.26e-04 | 19 | 62 | 2 | EFO_0021662 | |
| Disease | serum carcinoembryonic antigen measurement | 8.05e-04 | 20 | 62 | 2 | EFO_0005760 | |
| Disease | Ataxia | 1.26e-03 | 25 | 62 | 2 | C0004134 | |
| Disease | Early Pregnancy Loss | 1.58e-03 | 109 | 62 | 3 | C3830362 | |
| Disease | Miscarriage | 1.58e-03 | 109 | 62 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.58e-03 | 109 | 62 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 1.58e-03 | 109 | 62 | 3 | C0000822 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.59e-03 | 28 | 62 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.70e-03 | 29 | 62 | 2 | C4721806 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLQQNDQQLVYSLPF | 736 | Q8WWZ7 | |
| LPLLTRAENYAQIQN | 291 | Q9H161 | |
| LQALLLQRPQHYNQT | 171 | Q96Q91 | |
| LEIRNNAANYLPQIS | 411 | Q86TW2 | |
| LLLLYQAQQPQAALL | 726 | Q8N5R6 | |
| IYNNIPANLRQQAEV | 201 | O76031 | |
| LYSVQQQLQQPQQTL | 91 | Q8IX12 | |
| IYPNASLLIQNIIQN | 101 | P06731 | |
| VNNPSTQIYQLQALA | 16 | A8MVX0 | |
| PIYELVTNNQTQRLL | 976 | O14525 | |
| LEDPYSQQIRLQQQQ | 931 | Q9NVH2 | |
| NQVSTPLLRNVQFNY | 491 | P19823 | |
| IYPNASLLIQNVTQN | 101 | P40199 | |
| IQLVVQSVYNNLLPQ | 6081 | Q5CZC0 | |
| VQYTLPLELINQQNL | 211 | O95373 | |
| QDYLIALSLQQQQPR | 391 | Q8N5J2 | |
| ANIQPNRVTYQRLIA | 191 | P42704 | |
| INPVAYQQILSQQRG | 291 | P10070 | |
| DIGRTNLIVNYLPQN | 16 | Q15717 | |
| RPTKQNNQVAIVYNI | 686 | P17301 | |
| QRQYSLLQAANLLTP | 516 | Q86Y91 | |
| YARLLQQQQLFLQLQ | 286 | Q8IZQ8 | |
| IQQIPVQLNAGQLQY | 236 | Q13952 | |
| VQLNAGQLQYIRLAQ | 241 | Q13952 | |
| YNSQQQLFQRPNALA | 381 | Q14671 | |
| QLFQRPNALAVQQLT | 386 | Q14671 | |
| FQYQLRQTNQPLDVN | 11 | Q9UJ42 | |
| VDSYRQQQQLLQRPS | 386 | O15350 | |
| DSVIQLLNPNRQTIY | 71 | Q9BY67 | |
| PNYSRAQQQLIALIQ | 736 | Q9BXL6 | |
| QYVPQLQNNTILRLL | 426 | Q14152 | |
| IYPNASLLIQNVTQN | 101 | P13688 | |
| LRVTLQPYNVAQLQS | 191 | Q9Y6R7 | |
| NQAILSQLYQSPNRR | 211 | Q12926 | |
| QLRQVRDQQNLPYGV | 601 | Q7KZI7 | |
| PVQTQNQLVYFIRQA | 131 | Q9P225 | |
| RLYQGINQLPNVIQA | 406 | P43246 | |
| QQSPYIQRVLLTQQE | 96 | Q05469 | |
| QEQPNLLQQLLQYTV | 261 | A6NGG8 | |
| RIQQQIVQLLPDSSY | 181 | O15397 | |
| LVQYALPLQLVNNQT | 211 | O15397 | |
| LPQSIQQALRYLRSN | 676 | Q9Y3M8 | |
| QTQLQPRAVVALEYQ | 11 | P34981 | |
| QPLLNIQNYPQQISV | 61 | Q9HCM1 | |
| LRNLNIINTHAYNQP | 466 | Q15678 | |
| RAQNPLGSQQVYLNV | 321 | Q9Y336 | |
| YILATQQNNLPRTEN | 6 | Q96LD1 | |
| KQVSNLPQANYNLLR | 271 | Q7Z5H3 | |
| LLIQDIYQQQRASPA | 861 | G9CGD6 | |
| YLNALLATRAQNLPQ | 646 | Q8NE01 | |
| QVSNEPGNRYNLQLI | 2201 | A5YKK6 | |
| QVLPYLSQEHQQQVL | 91 | Q08117 | |
| LQLPNFQQSVQEYRR | 451 | Q9BQ52 | |
| LNVPAADLLQYNRAQ | 276 | Q6NXR4 | |
| QILQQKPAQYLRFNQ | 661 | O75038 | |
| KPAQYLRFNQQQLSR | 666 | O75038 | |
| QTRIIQQPLIYQNAA | 161 | Q12772 | |
| NSLLNQTQQPYRYLI | 616 | Q8WXW3 | |
| NDLVSPQYLNLIANL | 706 | Q92626 | |
| LSQLNLSYNPIQKIQ | 321 | Q9HBX9 | |
| IALLNIYRNPQNSSQ | 46 | Q01081 | |
| QQLRQQLYQSHQPLP | 181 | Q9UGU0 | |
| IVLLNLYRNPQNTAQ | 46 | Q8WU68 | |
| LENSLPQCYQRVQQL | 301 | Q8NEW0 | |
| QHQQLQYQQPSISVL | 636 | Q9H4A3 | |
| YQRIERNLQSPTQFQ | 441 | O75385 | |
| TLPVNSQNIQPVRYN | 346 | Q13887 | |
| LQAIARSQPLARQYQ | 816 | Q6PIF6 |